23/04/2014 - 16:15
WASHINGTON – Long-term dual-antiplatelet therapy may provide a mortality benefit over aspirin alone in patients with symptomatic peripheral artery disease.
In an observational study of 629 patients...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology